187 related articles for article (PubMed ID: 9396810)
21. HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.
Ambrosino C; Ruocco MR; Chen X; Mallardo M; Baudi F; Trematerra S; Quinto I; Venuta S; Scala G
J Biol Chem; 1997 Jun; 272(23):14883-92. PubMed ID: 9169458
[TBL] [Abstract][Full Text] [Related]
22. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
23. Exon 1 leader sequences downstream of U5 are important for efficient human immunodeficiency virus type 1 gene expression.
Lenz C; Scheid A; Schaal H
J Virol; 1997 Apr; 71(4):2757-64. PubMed ID: 9060629
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional elongation by purified RNA polymerase II is blocked at the trans-activation-responsive region of human immunodeficiency virus type 1 in vitro.
Bengal E; Aloni Y
J Virol; 1991 Sep; 65(9):4910-8. PubMed ID: 1870206
[TBL] [Abstract][Full Text] [Related]
25. Trans-activation by HIV-1 Tat via a heterologous RNA binding protein.
Selby MJ; Peterlin BM
Cell; 1990 Aug; 62(4):769-76. PubMed ID: 2117500
[TBL] [Abstract][Full Text] [Related]
26. Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.
Kao SY; Calman AF; Luciw PA; Peterlin BM
Nature; 1987 Dec 3-9; 330(6147):489-93. PubMed ID: 2825027
[TBL] [Abstract][Full Text] [Related]
27. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
Wright S; Luccarini C
J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus type 1 tat directs transcription through attenuation sites within the mouse c-myc gene.
Wright S; Lu X; Peterlin BM
J Mol Biol; 1994 Nov; 243(4):568-73. PubMed ID: 7525969
[TBL] [Abstract][Full Text] [Related]
30. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
Neuveut C; Vigne R; Clements JE; Sire J
Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
[TBL] [Abstract][Full Text] [Related]
31. Requirement of the human immunodeficiency virus type 1 env gene sequence for TAR-independent trans activation by Tat from the major immediate-early promoter of murine cytomegalovirus.
Kim YS
Biochem Biophys Res Commun; 1994 Sep; 203(2):1152-9. PubMed ID: 8093034
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors.
Kato H; Sumimoto H; Pognonec P; Chen CH; Rosen CA; Roeder RG
Genes Dev; 1992 Apr; 6(4):655-66. PubMed ID: 1559613
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs.
Kashanchi F; Sadaie MR; Brady JN
Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142
[TBL] [Abstract][Full Text] [Related]
34. HIV-1 Tat overcomes inefficient transcriptional elongation in vitro.
Laspia MF; Wendel P; Mathews MB
J Mol Biol; 1993 Aug; 232(3):732-46. PubMed ID: 7689112
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of c-Fos in activated T lymphoid and monocytic cells by human immunodeficiency virus-1 Tat protein.
Gibellini D; Caputo A; Capitani S; La Placa M; Zauli G
Blood; 1997 Mar; 89(5):1654-64. PubMed ID: 9057648
[TBL] [Abstract][Full Text] [Related]
36. Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M; Mathews MB
Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10018-22. PubMed ID: 1658792
[TBL] [Abstract][Full Text] [Related]
37. Electrostatic interactions modulate the RNA-binding and transactivation specificities of the human immunodeficiency virus and simian immunodeficiency virus Tat proteins.
Tao J; Frankel AD
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1571-5. PubMed ID: 8434019
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
Toyama R; Bende SM; Dhar R
Nucleic Acids Res; 1992 May; 20(10):2591-6. PubMed ID: 1598218
[TBL] [Abstract][Full Text] [Related]
39. Construction and characterization of a potent HIV-2 Tat transdominant mutant protein.
Echetebu CO; Rhim H; Herrmann CH; Rice AP
J Acquir Immune Defic Syndr (1988); 1994 Jul; 7(7):655-64. PubMed ID: 8207644
[TBL] [Abstract][Full Text] [Related]
40. Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene.
Huber BE; Richards CA; Martin JL; Wirth PJ
Mol Carcinog; 1992; 5(4):293-300. PubMed ID: 1379815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
